YU105689A - Process for producing optically active naphtothiazepines - Google Patents

Process for producing optically active naphtothiazepines

Info

Publication number
YU105689A
YU105689A YU01056/89A YU105689A YU105689A YU 105689 A YU105689 A YU 105689A YU 01056/89 A YU01056/89 A YU 01056/89A YU 105689 A YU105689 A YU 105689A YU 105689 A YU105689 A YU 105689A
Authority
YU
Yugoslavia
Prior art keywords
naphtothiazepines
optically active
producing optically
producing
active
Prior art date
Application number
YU01056/89A
Other languages
English (en)
Inventor
D L Coffen
P B Madan
A Schwartz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of YU105689A publication Critical patent/YU105689A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
YU01056/89A 1988-05-24 1989-05-23 Process for producing optically active naphtothiazepines YU105689A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19793488A 1988-05-24 1988-05-24

Publications (1)

Publication Number Publication Date
YU105689A true YU105689A (en) 1990-12-31

Family

ID=22731334

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01056/89A YU105689A (en) 1988-05-24 1989-05-23 Process for producing optically active naphtothiazepines

Country Status (14)

Country Link
EP (1) EP0343474A3 (fr)
JP (1) JPH0217170A (fr)
KR (1) KR900018002A (fr)
CN (1) CN1038639A (fr)
AU (1) AU3509989A (fr)
DK (1) DK250689A (fr)
FI (1) FI892506A (fr)
HU (1) HU204027B (fr)
IL (1) IL90366A0 (fr)
MC (1) MC2028A1 (fr)
NO (1) NO892068L (fr)
PT (1) PT90636A (fr)
YU (1) YU105689A (fr)
ZA (1) ZA893392B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
IT1230057B (it) * 1989-04-13 1991-09-27 Zambon Spa Processo di risoluzione di intermedi utili per la preparazione di 1,5-benzotiazepine
DE69015682T2 (de) * 1989-04-28 1995-05-11 Tanabe Seiyaku Co Verfahren zur Herstellung von 1,5-Benzothiazepinderivaten.
US5128469A (en) * 1989-04-28 1992-07-07 Tanabe Seiyaku Co., Ltd. Process for preparing 1,5-benzothiazepine derivatives
JPH0798813B2 (ja) * 1989-04-28 1995-10-25 田辺製薬株式会社 １，５―ベンゾチアゼピン誘導体の製法
IT1234387B (it) * 1989-07-12 1992-05-18 Zambon Spa Processo di purificazione di intermedi utili nella preparazione del diltiazem
AU628217B2 (en) * 1989-08-31 1992-09-10 Marion Merrell Dow Inc. Heterogeneous synthesis of azepinones from esters
US5250680A (en) * 1989-08-31 1993-10-05 Merrell Dow Pharmaceuticals Inc. Heterogeneous synthesis of azepinones from esters
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 １，５−ベンゾチアゼピン誘導体の製法
US5055575A (en) * 1990-04-12 1991-10-08 Tanabe Seiyaku Co., Ltd. Process for preparing 1,5-benzothiazepine derivatives
JP2601224Y2 (ja) * 1992-03-06 1999-11-15 株式会社キャットアイ 脈拍計
AU709280B2 (en) * 1996-02-23 1999-08-26 Tanabe Seiyaku Co., Ltd. Process for preparing 1,5-benzothiazepine derivative
KR19990041269A (ko) 1997-11-21 1999-06-15 이병훈 건강시계
JP3961505B2 (ja) * 2004-04-13 2007-08-22 松下電器産業株式会社 電圧検出回路、電源装置及び半導体装置
CN103304514B (zh) * 2013-06-28 2014-09-17 天津梅花医药有限公司 一种稳定性好的盐酸地尔硫卓化合物及药物组合物
CN111138243B (zh) * 2019-12-27 2022-06-24 郑州手性药物研究院有限公司 (1s,2r)-2-苯基环己醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145160A (ja) * 1984-12-20 1986-07-02 Nippon Chemiphar Co Ltd 光学活性なプロピオン酸誘導体の製造法
JPS61268663A (ja) * 1985-05-22 1986-11-28 Fuji Kagaku Kogyo Kk 光学活性な２−ヒドロキシ−３，３−ジ置換プロピオン酸の製造方法
US4652561A (en) * 1986-02-26 1987-03-24 Hoffmann-La Roche Inc. Naphtho[1,2-b]-1,4-thiazepinones

Also Published As

Publication number Publication date
IL90366A0 (en) 1989-12-15
FI892506A (fi) 1989-11-25
EP0343474A2 (fr) 1989-11-29
ZA893392B (en) 1990-01-31
NO892068D0 (no) 1989-05-23
CN1038639A (zh) 1990-01-10
AU3509989A (en) 1989-11-30
JPH0217170A (ja) 1990-01-22
PT90636A (pt) 1989-11-30
HU204027B (en) 1991-11-28
KR900018002A (ko) 1990-12-20
HUT50758A (en) 1990-03-28
FI892506A0 (fi) 1989-05-23
NO892068L (no) 1989-11-27
MC2028A1 (fr) 1990-04-25
DK250689D0 (da) 1989-05-23
DK250689A (da) 1989-11-25
EP0343474A3 (fr) 1991-01-23

Similar Documents

Publication Publication Date Title
EP0266217A3 (en) Process for producing optically active compounds
HUT49884A (en) Process for producing tert-butyl-3-oxobutyrate
EP0288994A3 (en) Process for producing optically active compounds
HUT55411A (en) Process for producing 9-hydroxy-17-methylene-steroides for producing corticosteriodes
YU105689A (en) Process for producing optically active naphtothiazepines
EP0459455A3 (en) Process for producing optically active alpha-hydroxyesters
HUT54409A (en) Process for producing new somatotropin-analogues
HUT64105A (en) Process for producing optically active cyanohydrines
HUT51333A (en) Process for producing new expression system
EP0290878A3 (en) Optically active compounds and process for producing thereof
EP0328101A3 (en) Process for producing alkylenamines
DE3465185D1 (en) Process for producing optically active cyclopentenolones
HUT49585A (en) Process for producing 1-alkyl-5-nitroimidazoles
EP0375554A3 (en) Process for producing optically active threo-dihydroxyphenylserine derivatives
EP0258967A3 (en) Process for producing optically active alcohols
HUT53941A (en) Process for producing l-treonine
HU204533B (en) Process for producing n-phosphono-methyl-glycine
HUT50124A (en) Process for producing 2-chloro-5-methyl-pyridine
HU894784D0 (en) Process for producing 1-alanine
HU206699B (en) Process for producing optically active n-acyl-n-phenyl-amino-tetrahydro-furanone
YU217089A (en) Process for producing ketoxymosylane
HUT47247A (en) Process for producing optically active oxo-isoindolinyl derivatives
DE3565530D1 (en) Process for producing optically active phenylalanine
EP0353053A3 (en) Catalytic process for producing optically active alpha-hydroxycarboxylates
YU95089A (en) Process for producing optic active naphtothiazepinone